Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Azithromycin recalled?

Not under an active recall. Azithromycin was recalled 13 times in the past — all now closed. Most recent: Apr 13, 2022.

Most common reason: cGMP deviation (9 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Azithromycin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Azithromycin recalls on record

none so far in 2026; 13 on record, newest first
Class II · Moderate risk

Azithromycin tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-278-11 D-1223-2015
Class II · Moderate risk

Azithromycin tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-464-11 D-1222-2015
Class II · Moderate risk

Azithromycin tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-279-11 D-1221-2015
Class II · Moderate risk

Azithromycin 500 mg tablets

cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.

Terminated cGMP deviation PD-Rx Pharmaceuticals, Inc. D-0561-2016
Class II · Moderate risk

Azithromycin Tablets

cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.

Terminated cGMP deviation PD-Rx Pharmaceuticals, Inc. D-0560-2016
Class II · Moderate risk

Azithromycin Tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1264-2015
Class II · Moderate risk

Azithromycin Tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1263-2015
Class II · Moderate risk

Azithromycin Tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1248-2015
Class II · Moderate risk

Azithromycin 100 mg Rectal Suppository

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1040-2015
Class II · Moderate risk

Azithromycin Dihydrate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-533-2015